Neogen (NASDAQ:NEOG) Share Price Crosses Above 50 Day Moving Average – Time to Sell?

Posted by Francis Steltz on Oct 28th, 2026

Neogen Corporation (NASDAQ:NEOG – Get Free Report) shares crossed above its 50 day moving average during trading on Monday. The stock has a 50 day moving average of $12.20 and traded as high as $12.35. Neogen shares last traded at $12.21, with a volume of 1,691,236 shares.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on NEOG. Piper Sandler upgraded Neogen from a “neutral” rating to an “overweight” rating and lifted their target price for the company from $13.00 to $14.00 in a research report on Wednesday, August 26th. Guggenheim reaffirmed a “buy” rating and set a $14.00 target price (up from $12.00) on shares of Neogen in a research report on Wednesday, September 30th. Weiss Ratings upgraded shares of Neogen from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, August 7th. Finally, Wall Street Zen lowered Neogen from a “strong-buy” rating to a “buy” rating in a research report on Sunday, October 11th. Three equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Neogen has an average rating of “Hold” and a consensus target price of $12.67.

View Our Latest Stock Report on Neogen

Neogen Price Performance

The company has a fifty day moving average of $12.22 and a 200-day moving average of $10.39. The firm has a market cap of $2.65 billion, a P/E ratio of -48.48, a P/E/G ratio of 4.46 and a beta of 1.79. The company has a debt-to-equity ratio of 0.37, a current ratio of 3.90 and a quick ratio of 2.92.

Neogen (NASDAQ:NEOG – Get Free Report) last released its quarterly earnings results on Tuesday, October 6th. The company reported $0.08 earnings per share for the quarter, topping the consensus estimate of $0.05 by $0.03. Neogen had a negative net margin of 6.35% and a positive return on equity of 3.29%. The business had revenue of $222.80 million for the quarter, compared to analysts’ expectations of $208.18 million. During the same period in the previous year, the company earned $0.04 earnings per share. The firm’s revenue for the quarter was up 6.5% compared to the same quarter last year. On average, sell-side analysts anticipate that Neogen Corporation will post 0.27 EPS for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Bank of America Corp DE bought a new position in Neogen during the second quarter worth about $28,280,000. Bank of New York Mellon Corp bought a new position in shares of Neogen in the second quarter worth $11,404,000. Sei Investments Co. increased its stake in Neogen by 69.1% in the 1st quarter. Sei Investments Co. now owns 230,403 shares of the company’s stock worth $2,141,000 after acquiring an additional 94,148 shares during the last quarter. The Manufacturers Life Insurance Company purchased a new stake in Neogen in the second quarter valued at approximately $956,000. Finally, Arrowstreet Capital Limited Partnership purchased a new stake in Neogen in the first quarter valued at approximately $2,980,000. 96.73% of the stock is currently owned by hedge funds and other institutional investors.

Neogen Company Profile

(Get Free Report)

Neogen Corporation develops and markets products and services designed to help protect the food supply and support animal health. Its food safety offerings include diagnostic tests and laboratory products used to detect pathogens, allergens, mycotoxins, genetically modified organisms, veterinary drug residues, and other contaminants in food and agricultural environments.

The company also provides sanitation and hygiene products, environmental monitoring solutions, and software and data-management tools that help food processors, retailers, laboratories, and other organizations manage food safety programs.